Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.1992
-0.0030 (-1.48%)
At close: Oct 22, 2026, 4:00 PM EDT
0.1747
-0.0245 (-12.30%)
Pre-market: Oct 23, 2026, 5:51 AM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $3.97 million as of October 22, 2026. It is the 45,794th most valuable company in the world and the 6,117th biggest in the United States. Its market cap has decreased by 85.09% in one year.
Market Cap
3.97M
Enterprise Value
15.99M
1-Year Change
-85.09%
Global Rank
Country Rank
#6,117 United States
Category
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $3.97M, a decrease of -96.10%. That is a compound annual growth rate of -34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.97M | -97.62% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 4.66M |
| Longeveron | 4.56M |
| Azitra | 4.33M |
| Liminatus Pharma | 4.19M |
| NuCana | 4.15M |
| PharmaCyte Biotech | 3.73M |
| KALA BIO | 3.69M |
| Jupiter Neurosciences | 3.67M |